| 1. |
- Danermark, Berth, 1951-, et al.
(författare)
-
Hearing and vision : health in Sweden: The National Public Health Report 2012. Chapter 17
- 2012
-
Ingår i: Scandinavian Journal of Public Health. - London, United Kingdom : Sage Publications. - 1403-4948 .- 1651-1905. ; 40:suppl9, s. 287-292
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Over a million people in Sweden have difficulty hearing what is said in a conversation between several people. Almost twice as many young people today consider themselves hard of hearing than was the case 10 years ago. However, this self-reported increase has not been confirmed by studies of hearing loss.At least 10,000 deaf and hearing-impaired people are under the age of 20. In most cases, their hearing impairments are the result of hereditary factors. People who have impaired hearing report having worse health than those with normal hearing. This is particularly true of younger, actively employed people.Many people who are hard of hearing suffer unnecessarily because they lack the hearing-aid devices they need. Almost half the people who would benefit from a hearing aid do not have one. Only a quarter of hearing-impaired people use other assistive listening devices, such as amplified sound in telephones and doorbells.One in every two Swedes over the age of 16 needs glasses to read plain text in a daily newspaper. One per cent of the population is unable to read text in a daily newspaper with or without glasses to help them. It is slightly less common today than 10 years ago for older women to have impaired vision. This is probably because cataracts, the most common cause of impaired vision, are operable. Most people given cataract surgery regain very good vision.The most common cause of blindness in older people is age-related degeneration of the macula lutea. The treatment currently available is only effective with a small group of people among those who suffer from acute problems. Strabism can result in vision impairment if not treated early. Child healthcare centres and schools offer screening procedures for detecting strabism. As a result, the percentage of people in the population with this condition has declined to just under 2 per cent.
|
|
| 2. |
- Danermark, Berth, 1951-, et al.
(författare)
-
Hörsel och syn
- 2009
-
Ingår i: Folkhälsorapport 2009. - Stockholm : Socialstyrelsen. - 9789197806589 ; , s. 417-424
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 3. |
|
|
| 4. |
- Fredriksson, Mio, et al.
(författare)
-
Regional media coverage influences the public's negative attitudes to policy implementation success in Sweden
- 2015
-
Ingår i: Health Expectations. - : Wiley. - 1369-6513 .- 1369-7625. ; 18:6, s. 2731-2741
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: One central aspect of health literacy is knowledge of patients' rights. Being an important source of information about health and health care, the media may influence health literacy and act as a policy implementer.OBJECTIVE: To investigate whether regional news media coverage in Sweden is linked to (i) the public's awareness and knowledge of a patient's rights policy, the waiting-time guarantee and (ii) the public's attitudes to how the guarantee's time limits are met, that is, implementation success.DESIGN AND DATA: Three types of data are used. First, a national telephone survey of the public's awareness, knowledge and attitudes; second, media coverage information from digital media monitoring; and third, official waiting-time statistics. Bivariate and multivariate regression analyses are performed with the 21 Swedish county councils/regions as a base.RESULTS: In the county councils/regions, non-awareness ranged from 1 to 15% and knowledge from 47 to 67%. There are relatively large differences between population groups. The amount of regional media coverage shows no significant correlation to the level of awareness and knowledge. There is, however, a significant correlation to both positive and negative attitudes; the latter remains after controlling for actual waiting times.DISCUSSION AND CONCLUSIONS: At the national level, the media function as a policy implementer, being the primary source of information. At the regional level, the media are part of the political communication, reporting more extensively in county councils/regions where the population holds negative views towards the achievement in implementing the guarantee. We conclude that Swedish authorities should develop its communication strategies to bridge health literacy inequalities.
|
|
| 5. |
- Hanning, Marianne, et al.
(författare)
-
Assessment of the Maximum Waiting time Guarantee for Cataract Surgery : The Case of a Swedish Policy
- 1998
-
Ingår i: International Journal of Technology Assessment in Health Care. - : Cambridge U.P.. - 0266-4623 .- 1471-6348. ; 14:1, s. 180-193
-
Tidskriftsartikel (refereegranskat)abstract
- Cataract is the most common reason for visual problems in old age. The introduction of intraocular lens (IOL) implantation revolutionized cataract surgery. Since the IOL technique was established in Sweden in the early 1980s, the demand for surgery has been increasing, leading to lengthy waiting lists. To shorten some of the most troublesome waiting lists, national and local governments (county councils) in Sweden introduced a maximum waiting time guarantee in 1992. The assessment of the guarantee made in this article shows that ophthalmic surgery units vary in their adoption of the guarantee, leading to different levels of goal achievement in waiting times for their patients. The less successful units could be divided into two groups: one where the units have a low operation rate, and one where the units chose not to follow the recommendations in priority setting made in the guarantee.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Hanning, Marianne, et al.
(författare)
-
Impact of increased patient choice of providers in Sweden : cataract surgery
- 2012
-
Ingår i: Journal of Health Services Research and Policy. - : SAGE Publications. - 1355-8196 .- 1758-1060. ; 17:2, s. 101-105
-
Tidskriftsartikel (refereegranskat)abstract
- Objectives Choice of provider was introduced in Sweden in 2001. Our aim was to describe the scope and character of patient flows and to analyze any differences between patients who chose to move outside of their home county (movers) and those who did not (non-movers) with regard to age, sex, waiting time and level of need.Methods Use of cataract operations between 2005 and 2008 based on data from the National Cataract Register. Data were analysed using descriptive statistics, odds ratios and multivariate regression analysis to compare movers and non-movers. Information on contracting between county councils and providers in other counties was obtained from a survey.Results Only 4% of cataract patients were treated by a provider outside their home county. Patient flows were mainly determined by contracts between county councils and providers, and only 1% were considered to be 'true' movers (i.e. patients who were not part of any special contracting agreement). Movers differed from non-movers in that they were on average younger, had less serious visual problems and had shorter waiting times.Conclusion Though patient flows are minor in scope, the possibility of changing provider has probably been important in tackling long waits in some counties. However, the reform may threaten the equity of health care use.
|
|
| 9. |
- Hanning, Marianne, et al.
(författare)
-
Köer och väntetider i sjukvården : det politiska perspektivet : intervjustudie med sjukvårdspolitiker i den södra sjukvårdsregionen våren 1997.
- 1997
-
Bok (övrigt vetenskapligt/konstnärligt)abstract
- Denna studie ingår i ett projekt där Landstingsförbundet, Samverkansnämndens kansli och sjukvårdshuvudmännen i den södra sjukvårdsregionen samarbetar för att ta fram ett förslag till uppföljningsmodell vad gäller köer och väntetider i sjukvården. Syftet med denna studie var att studera den landstingspolitiska nivåns uppfattning och upplevelse av köer och väntetider. I studien intervjuades sammanlagt 12 ledamöter i Södra samverkansnämnden. Intervjustudien visar att tillgänglighetsfrågor är mycket centrala i den lokala politiska debatten om sjukvården. Det var en allmän uppfattning att det inte enbart rör sig om resursbrist utan att det är fråga om komplicerade samband mellan många olika faktorer.
|
|
| 10. |
- Hanning, Marianne, et al.
(författare)
-
Maximum waiting time - a threat to clinical freedom? : Implementation of a policy to reduce waiting times
- 2000
-
Ingår i: Health Policy. - 0168-8510 .- 1872-6054. ; 52:1, s. 15-32
-
Tidskriftsartikel (refereegranskat)abstract
- This article focuses on physicians as implementers of health policy reforms. In 1992, a maximum waiting-time guarantee was introduced in Sweden. Initially the policy was a successful way to come to terms with long waiting times. However, after 2 years the waiting lists started to increase. To understand this development it is important to look at the reactions to the policy among the implementers, i.e. the physicians. Three questions are addressed: Did the implementers understand the intentions and the goals of the reform? Were they able to fulfil the guarantee? And, did they approve of the initiative? The study subjects were chief physicians at the hospital departments involved with the guarantee. Their attitudes towards the policy were ascertained by two surveys. Other material, such as statistics on waiting times, was also used. The study shows that the physicians approved of the guarantee initially. The measures taken in the first years were effective and did not conflict with earlier practice. However, increased demand in combination with economic restraints necessitated new priorities among patient groups. These changes of clinical practice did not coincide with the physicians’ professional values and hence they became more critical to the initiative and finally chose to abandon the intentions in the guarantee.
|
|
| 11. |
- Hanning, Marianne, 1952-
(författare)
-
Maximum Waiting-time Guarantee - a remedy to long waiting lists? : Assessment of the Swedish Waiting-time Guarantee Policy 1992-1996
- 2005
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Lengthy waiting times have been a problem in Swedish health services for many years. In 1992, Sweden implemented a national maximum waiting-time guarantee (MWG) through an agreement between the Swedish Government and the Federation of Swedish County Councils. The “guarantee” assured patients that the waiting time between the decision-to-treat and the treatment itself would not exceed three months. The national MWG covered twelve different treatments/interventions and remained in force for five years. This dissertation describes the genesis of the MWG, its implementation, and its effects.Four papers serve as a foundation for the dissertation. Paper I describes how the guarantee was implemented during the first two years. Paper II studies the impact that the MWG had on cataract surgery. Paper III uses the results of two questionnaire surveys of department heads to explain why the MWG, although successfully launched, became increasingly difficult to maintain. Paper IV analyses data from the national cataract register to determine how production and waiting times in cataract surgery were affected by termination of the MWG.This dissertation confirms that waiting time for health care is a complex phenomenon resulting from multiple causes. “Guarantees” are of particular interest because they define what constitutes too long in reference to waiting times. Beyond that, they are only a framework for developing a plan of action. The positive effects of the MWG were transient and based on rationalisation, introduction of new technology, and stricter prioritisation. The MWG contributed towards empowering patients and slowing the expansion of treatment indications, but it was unsuccessful in levelling out the wide regional variations in surgical rates.
|
|
| 12. |
- Hanning, Marianne
(författare)
-
Maximum Waiting-time Guarantee - an attempt to reduce waiting lists in Sweden
- 1996
-
Ingår i: Health Policy. - : Elsevier BV. - 0168-8510 .- 1872-6054. ; 36:1, s. 17-35
-
Tidskriftsartikel (refereegranskat)abstract
- In Sweden, as in most countries with publicly financed health services, long waiting lists for some surgical procedures have been a serious quality problem on the health policy agenda. To reduce waiting lists, the Swedish Government and the Federation of County Councils, agreed on an initiative to offer a maximum waiting-time guarantee for 12 procedures during 1992. Patients awaiting procedures are guaranteed a waiting time no longer than 3 months from the physician's decision to treat/operate. The initial agreement was to be in force for 1 year, and a grant of 500 million SEK (USD 70 million) was appropriated for the initiative. The guarantee has been prolonged by annual decisions to be in force 1993 through 1995. However, no extra resources were set aside for these years. This article describes the background and the introduction of the guarantee, and discusses some of the major results during the first 2 years. Generally, waiting lists decreased substantially during 1991 and 1992. By the end of 1992 only a few departments were unable to serve patients within 3 months. During 1993 the reduction in the waiting lists ceased, and waiting lists for some procedures showed a tendency to increase by the end of the year. The overall successful result, in terms of waiting lists and waiting times, seems to have been achieved mainly by increased production, improved administration of the waiting lists, and a change in attitudes toward waiting lists. The expectation that the guarantee would lead to a more even use of resources across the country has not been realised since it appears that hospital departments chose to expand their own activities rather than use the new opportunity offered by the guarantee to refer patients to other hospitals.
|
|
| 13. |
- Hanning, Marianne, et al.
(författare)
-
Nationella medicinska indikationer. Nyckeln till evidensbaserad, rättvis och tillgänglig vård.
- 2008
-
Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 105:6, s. 363-366
-
Tidskriftsartikel (refereegranskat)abstract
- Det finns stora regionala skillnader i frekvens för olika behandlingar inom vården. Vårdgarantin och patienternas valmöjligheter innebär att detta förhållande på nytt måste bli föremål för åtgärder. De regionala variationerna beror ofta på att indikationerna förändras och indikationsgränser för etablerade behandlingar förskjuts i takt med att ny kunskap implementeras och tillämpas i klinisk praxis. I samband med införandet av vårdgarantin beslutade man att starta ett utvecklingsarbete kring »nationella medicinska indikationer«. Indikationsarbeten inom sex områden har hittills redovisats. Ytterligare ett tiotal har pågått under 2007. Samtliga grupper som hittills avslutat sina uppdrag har presenterat förslag till nationella medicinska indikationer förankrade inom sina specialistföreningar. Generellt gäller att där behandlingsfrekvenser finns redovisade är de regionala variationerna omfattande. Förslag till remiss- och bedömningsmallar har presenterats för flertalet av diagnosgrupperna. Mycket talar för att indikationsarbetet kan vara nyckeln till att utveckla en mer kunskapsbaserad styrning av vården och därmed utgöra ett komplement till Socialstyrelsens riktlinjearbete. Praktisk tillämpning av indikationsarbetet kan innebära att vården blir mer evidensbaserad, rättvis, tillgänglig och patientorienterad än vad som är fallet i dag. För att indikationerna ska vara meningsfulla måste de ständigt ses över och omprövas i takt med nya medicinska rön. En särskild nationell funktion för detta bör inrättas.
|
|
| 14. |
- Hanning, Marianne, et al.
(författare)
-
Tillgänglighet och valfrihet
- 1995
-
Ingår i: Sjukvården i Sverige. - Stockholm : Socialstyrelsen. - 917201069X
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 15. |
|
|
| 16. |
- Hanning, Marianne, et al.
(författare)
-
Waiting fo Cataract Surgery - Effects of Maximum Waiting-time Guarantee policy
- 2007
-
Ingår i: Journal of Health Services Research and Policy. - : SAGE Publications. - 1355-8196 .- 1758-1060. ; 12:1, s. 5-10
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To evaluate the effects of the Maximum Waiting-time Guarantee (MWG) policy for cataract surgery on volume, indications, waiting times and priority setting in Sweden. Methods: Comparison between 1993 and 1994, when the guarantee had been in force for one year, and 1998 and 1999, when the policy had been terminated for one year. Data from the National Cataract Registry covering 156,657 cataract operations for the years studied. Results: The number of operations increased by 43% between the two study periods. Of this increase, 61% were patients with a visual acuity above 0.5 in the better eye, i.e. low-priority patients. Waiting times were longer for all patient categories in the later period and differences in waiting times between patients with differing priority diminished. Variations among the units in priority setting and waiting times were substantial, and increased after the Guarantee was terminated. Conclusions: The Guarantee with its explicit indications was an effective policy instrument to limit waiting times and improve access for patients with the greatest need. It is unlikely that the Guarantee caused any 'crowding out' of other patient groups. When the Guarantee was not in force, indications for surgery widened. This, however, resulted in longer waiting times for all patient groups. After the Guarantee was terminated, the already substantial differences in access and indications among ophthalmic units became even greater.
|
|
| 17. |
- Lundström, Mats, et al.
(författare)
-
Mer jämlik vård för patienter med katarakt : Resultat av införande av nationella operationsindikationer
- 2009
-
Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 106:26-27, s. 1733-1736
-
Tidskriftsartikel (refereegranskat)abstract
- Ett förslag till nationella indikationer för kataraktoperation lanserades i september 2005, och indikationsgrupp infördes som en variabel i nationella kataraktregistret i maj 2006. Andelen kataraktoperationer i Sverige som bedömts enligt de nationella indikationerna har legat på 80–85 procent sedan införandet. Omdömet från landets klinikchefer inom ögonspecialiteten har varit att idén med gemensamma nationella indikationer är bra. Effekten av införandet har bedömts som positiv när det gäller ökad patientmedverkan, minskad variation mellan kirurger i bedömning av operationsbehov och förbättrad hantering av vårdgarantin. Negativa effekter har varit ökad administration med nya formulär i rutinverksamheten och därmed försämrad arbetsmiljö. De nationella indikationerna har medfört att gränsdragningen mellan beslut om operation och avvaktan förtydligats. En majoritet av klinikerna följer dessa rekommendationer. Data från nationella kataraktregistret visar att variationen i operationsfrekvens mellan landstingen har minskat och att väntetiden kortats kraftigt för de mest angelägna indikationsgrupperna. Därmed har också vårdgarantin för dessa fungerat bättre och bättre
|
|
| 18. |
- Ohlsson, Anna, 1975-, et al.
(författare)
-
Effectiveness by gender and age of renin-angiotensin system blockade in heart failure-A national register-based cohort study
- 2020
-
Ingår i: Pharmacoepidemiology and Drug Safety. - : Wiley. - 1053-8569 .- 1099-1557. ; 29:5, s. 518-529
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: Investigate effectiveness by gender and age and equity implications of treatment with renin‐angiotensin system blockade (RASb) in heart failure (HF) patients.Methods: In this population‐based register study, we used inpatient data from 2006 to 2010 for patients age 20 years or older with no HF hospitalisation for minimum of 1 year before an index hospitalisation. A wash‐out period for RASb of 6 months preceding admission was used.Hospital data were linked with drug dispensation data and cause of death data. The associations between time‐dependent RASb exposure and all‐cause death and HF death, respectively, were examined by Cox regression models. Interactions by gender and age were also investigated on the multiplicative and additive scales.Results: Thirty thousand seven hundred twenty‐one patients were analysed. Fifty‐one percent were women. Median age was 83. Fifty‐three percent of women and 64% of men received RASb after the index hospitalisation. Younger patients were more likely to receive RASb than older ones. One‐year mortality was 28%. RASb was associated with an overall hazard ratio (HR) for all‐cause death of 0.72 (95% confidence interval 0.69‐0.75), and an HR of 0.85 (0.77‐0.93) for HF death. Interaction analyses showed HRs for all‐cause death associated with RASb between 0.12 (0.10‐0.13) in the youngest, and 0.80 (0.76‐0.84) in the oldest patients.Conclusions: RASb appeared effective for women and men and for patients of all ages in this hospitalised HF cohort. No gender difference in effectiveness was found. RASb exposure was low overall, indicating a need for improved adherence to treatment guidelines. Treatment with RASb may be inequitable for women and older patients.
|
|
| 19. |
- Ohlsson, Anna, 1975-
(författare)
-
Equity in Treatment and Outcomes among Heart Failure Patients in Sweden : The role of gender, age and socioeconomic factors in access to treatment and mortality
- 2021
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- There is extensive empirical evidence for inequity in health and health care between and within countries across all economic levels worldwide. In Sweden, the Health and Medical Services Act states that health care should provide good health and equal health care for the entire population, but this goal has yet to be fulfilled. Equity has been defined as “differences which are unnecessary and avoidable, but in addition are considered unfair and unjust”. Equity in health is closely linked with the so-called social determinants of health, or the conditions in which people are born, grow, live, work, and age.Heart failure (HF) is a common disease globally, carrying high morbidity and mortality, and is one of the major causes of hospitalisations in Sweden. There is a strong evidence base for renin angiotensin system blockers (RASb) as well as beta-blockers (BB) reducing mortality in HF, and long-standing recommendations for these medications in treatment guidelines. However, not all eligible patients receive this first-line treatment. There has been some evidence of inequity by gender and age in treatment of HF, but evidence regarding socioeconomic risk factors has been scarce.In this thesis, differences in access to pharmacological therapy by demographic and socioeconomic factors were investigated.Observational studies with cohort designs were performed. In Study I–III large national population-level interlinked register materials were investigated, and in Study IV a well characterised cohort including clinical and prescription data from the SwedeHF, a Swedish HF quality register, was analysed.In Study I, we investigated differences in access to angiotensin-converting enzyme inhibitors (a type of RASb) by gender, age, educational level, employment status, income and immigration status among hospitalised HF patients in Sweden. In Study II we aimed to investigate effectiveness, i.e., the association between RASb exposure and mortality, among hospitalised HF patients in Sweden, and whether effectiveness varied with gender and age. In Study III, RASb access and mortality by employment status and educational level among hospitalised HF patients in Sweden of working age was analysed, along with possible excess mortality among non-employed patients without access to RASb. In Study IV, medication adherence to mortality-reducing HF medications, i.e., RASb and BB, was examined by age, gender, educational level, marital status and income.In conclusion, the studies in the thesis showed that access to RASb treatment appeared inequitable for women, the non-employed, and the elderly among hospitalised HF patients, although this treatment was associated with lower mortality for all these groups. Furthermore, RASb treatment was associated with similar reductions in mortality for women and men, but the association was somewhat weaker among older compared with younger hospitalised HF patients. In addition, non-employment and lower educational level were associated with higher mortality in hospitalised HF patients, and non-employment was associated with less access to RASb treatment. Finally, lower income and single status were associated with lower adherence to mortality-reducing treatment with BB and RASb in a quality register HF cohort, while associations were more unclear regarding gender and age.
|
|
| 20. |
|
|
| 21. |
|
|
| 22. |
- Ohlsson, Anna, 1975-, et al.
(författare)
-
Inequity of access to ACE inhibitors in Swedish heart failure patients : a register-based study
- 2016
-
Ingår i: Journal of Epidemiology and Community Health. - : BMJ. - 0143-005X .- 1470-2738. ; 70:1, s. 97-103
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Several international studies suggest inequity in access to evidence-based heart failure (HF) care. Specifically, studies of ACE inhibitors (ACEIs) point to reduced ACEI access related to female sex, old age and socioeconomic position. Thus far, most studies have either been rather small, lacking diagnostic data, or lacking the possibility to account for several individual-based sociodemographic factors. Our aim was to investigate differences, which could reflect inequity in access to ACEIs based on sex, age, socioeconomic status or immigration status in Swedish patients with HF.METHODS: Individually linked register data for all Swedish adults hospitalised for HF in 2005-2010 (n=93 258) were analysed by multivariate regression models to assess the independent risk of female sex, high age, low employment status, low income level, low educational level or foreign country of birth, associated with lack of an ACEI dispensation within 1 year of hospitalisation. Adjustment for possible confounding was made for age, comorbidity, Angiotensin receptor blocker therapy, period and follow-up time.RESULTS: Analysis revealed an adjusted OR for no ACEI dispensation for women of 1.31 (95% CI 1.27 to 1.35); for the oldest patients of 2.71 (95% CI 2.53 to 2.91); and for unemployed patients of 1.59 (95% CI 1.46 to 1.73).CONCLUSIONS: Access to ACEI treatment was reduced in women, older patients and unemployed patients. We conclude that access to ACEIs is inequitable among Swedish patients with HF. Future studies should include clinical data, as well as mortality outcomes in different groups.
|
|
| 23. |
- Ohlsson, Anna, 1975-, et al.
(författare)
-
Non-employment and low educational level as risk factors for inequitable treatment and mortality in heart failure : a population-based cohort study of register data
- 2021
-
Ingår i: BMC Public Health. - : Springer Nature. - 1471-2458. ; 21:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background: The risk of heart failure is disproportionately high among the socioeconomically disadvantaged. Furthermore, socioeconomically deprived patients are at risk of inequitable access to heart failure treatment and poor outcomes. Non-employment as a risk factor in this respect has not previously been studied at the level of the individual. The aim of this register-based cohort study was to analyse equity in access to renin-angiotensin system blockers and mortality, by employment status and educational level. Methods: The study population consisted of Swedish patients aged 20–64 years hospitalised for heart failure in July 2006–December 2010, without a heart failure hospitalisation within one year or more before index hospitalisation and without renin-angiotensin system blocker dispensation in the 6 months preceding index hospitalisation. Non-access to renin-angiotensin system blockers, measured as drug dispensations, was investigated by employment status and educational level through logistic regression. Cox regression models were used to obtain hazard ratios for all-cause death by educational level and employment status. Interaction analysis was used to test whether associations between access to treatment and mortality differed by employment status. Results: Among the 3,874 patients, 1,239 (32%) were women. The median age was 57 years. Fifty-three percent were employed. The non-employed patients had more comorbidity and lower access (68%) to renin-angiotensin system blockers compared with the employed (82%). The adjusted odds ratio for non-access to renin-angiotensin system blockers among the non-employed was 1.76. Non-employment was associated with an adjusted hazard ratio of 1.76 for death. Low educational level was associated with a higher death risk. Mortality was highest among the non-employed without access to renin-angiotensin system blockers and the association between access to renin-angiotensin system blockers and survival was slightly weaker in this group.Conclusions: Non-employment and low educational level were associated with elevated mortality in heart failure. Non-employment was a risk factor for lower access to evidence-based treatment, and among the non-employed access to treatment was associated with a slightly smaller risk reduction than among the employed. The results underscore that clinicians need to be aware of the importance of socioeconomic factors in heart failure care.
|
|
| 24. |
- Robertson, Stephanie, et al.
(författare)
-
Waiting times for cancer patients in Sweden : A nationwide population-based study
- 2017
-
Ingår i: Scandinavian Journal of Public Health. - : SAGE PUBLICATIONS LTD. - 1403-4948 .- 1651-1905. ; 45:3, s. 230-237
-
Tidskriftsartikel (refereegranskat)abstract
- Aims: The reported long waiting times for cancer patients have mostly been related to prognostic outcome and less to patient-related experience to outcome. We assessed waiting times for patients with cancer of the breast, prostate, colon or rectum in Sweden.Methods: The median time from referral to start of treatment was assessed using data from clinical cancer registers for patients who received curative treatment during 2011, 2012 and 2013.Results: The median overall waiting time in different counties ranged from 7 to 28 days for breast cancer, from 117 to 280 days for prostate cancer, from 27 to 64 days for colon cancer and from 48 to 80 days for rectal cancer. For the entire nation, the median time from referral to start of treatment remained unchanged from 2011 to 2013 for each cancer diagnosis.Conclusions: Large variations were found in waiting times between different counties in Sweden and between different types of cancer. The long waiting times identified in this study emphasize the need to improve national programmes for more rapid diagnosis and treatment.
|
|
| 25. |
- Winblad, Ulrika, et al.
(författare)
-
Sweden
- 2013
-
Ingår i: Waiting Time Policies in the Health Sector. - : OECD Publishing. - 9789264179080 - 9789264179066 ; , s. 275-292
-
Bokkapitel (populärvet., debatt m.m.)
|
|
